Bone health in eating disorders

Obesity Reviews

Volumn 15, Issue 3, 2014, Pages 215-223

  Zuckerman Levin, N ^a   Hochberg, Z ^b,c   Latzer, Y ^a,d  

^a RAMBAM MEDICAL CENTER   (Israel)

^b MEYER CHILDREN S HOSPITAL   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d UNIVERSITY OF HAIFA   (Israel)

Author keywords

Adolescents; Anorexia nervosa; Bone; Eating disorders; Endocrinology

Indexed keywords

ADOLESCENTS; ANOREXIA NERVOSA; BONE; EATING DISORDERS; ENDOCRINOLOGY;

ADOLESCENT; ADULT; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; EATING DISORDERS; FEMALE; HUMANS; WEIGHT GAIN; YOUNG ADULT;

EID: 84894250064     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12117     Document Type: Review

References (121)

1. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 2006; 19: 389-394.
2. Association AP. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press: Arlington, VA, 2000.
3. Warren MP. Anorexia nervosa and related eating disorders. Clin Obstet Gynecol 1985; 28: 588-597.
4. Robergeau K, Joseph J, Silber TJ. Hospitalization of children and adolescents for eating disorders in the State of New York. J Adolesc Health 2006; 39: 806-810.
5. Grinspoon S, Thomas E, Pitts S etal. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000; 133: 790-794.
6. Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999; 84: 4489-4496.
7. Misra M, Aggarwal A, Miller KK etal. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 2004; 114: 1574-1583.
8. Modan-Moses D, Yaroslavsky A, Novikov I etal. Stunting of growth as a major feature of anorexia nervosa in male adolescents. Pediatrics 2003; 111: 270-276.
9. Misra M. Long-term skeletal effects of eating disorders with onset in adolescence. Ann N Y Acad Sci 2008; 1135: 212-218.
10. Frydrych AM, Davies GR, McDermott BM. Eating disorders and oral health: a review of the literature. Aust Dent J 2005; 50: 6-15; quiz 56.
11. Lawson EA, Klibanski A. Endocrine abnormalities in anorexia nervosa. Nat Clin Pract Endocrinol Metab 2008; 4: 407-414.
12. Misra M, Soyka LA, Miller KK etal. Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2003; 88: 3816-3822.
13. Wong JC, Lewindon P, Mortimer R, Shepherd R. Bone mineral density in adolescent females with recently diagnosed anorexia nervosa. Int J Eat Disord 2001; 29: 11-16.
14. Serafinowicz E, Wasikowa R, Iwanicka Z, Jedrzejuk D. Bone metabolism in adolescent girls with short course of anorexia nervosa]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2003; 9: 67-71.
15. Milos G, Spindler A, Ruegsegger P etal. Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int 2005; 16: 783-790.
16. Biller BM, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989; 68: 548-554.
17. Karlsson MK, Weigall SJ, Duan Y, Seeman E. Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa. J Clin Endocrinol Metab 2000; 85: 3177-3182.
18. Faje AT, Karim L, Taylor A etal. Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. J Clin Endocrinol Metab 2013; 98: 1923-1929.
19. Castro J, Lazaro L, Pons F, Halperin I, Toro J. Predictors of bone mineral density reduction in adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2000; 39: 1365-1370.
20. Seibel MJ. Bone turnover in nutrition-related disorders. Wien Med Wochenschr 2007; 157: 582-588.
21. Misra M, Katzman DK, Cord J etal. Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 2008; 93: 3029-3036.
22. Misra M, Katzman DK, Clarke H etal. Hip structural analysis in adolescent boys with anorexia nervosa and controls. J Clin Endocrinol Metab 2013; 98: 2952-2958.
23. Bredella MA, Misra M, Miller KK etal. Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology 2008; 249: 938-946.
24. Soyka LA, Misra M, Frenchman A etal. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2002; 87: 4177-4185.
25. Lennkh C, de Zwaan M, Bailer U etal. Osteopenia in anorexia nervosa: specific mechanisms of bone loss. J Psychiatr Res 1999; 33: 349-356.
26. Mehler PS, Sabel AL, Watson T, Andersen AE. High risk of osteoporosis in male patients with eating disorders. Int J Eat Disord 2008; 41: 666-672.
27. Andersen AE, Watson T, Schlechte J. Osteoporosis and osteopenia in men with eating disorders. Lancet 2000; 355: 1967-1968.
28. Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002; 23: 279-302.
29. Lawson EA, Miller KK, Bredella MA etal. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 2010; 46: 458-463.
30. Walsh CJ, Phan CM, Misra M etal. Women with anorexia nervosa: finite element and trabecular structure analysis by using flat-panel volume CT. Radiology 2010; 257: 167-174.
31. Baum ML, Kramer EL, Sanger JJ, Pena A. Stress fractures and reduced bone mineral density with prior anorexia nervosa. J Nucl Med 1987; 28: 1506-1507.
32. Vestergaard P, Emborg C, Stoving RK, Hagen C, Mosekilde L, Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders-a nationwide register study. Int J Eat Disord 2002; 32: 301-308.
33. Zipfel S, Seibel MJ, Lowe B, Beumont PJ, Kasperk C, Herzog W. Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab 2001; 86: 5227-5233.
34. Herzog W, Minne H, Deter C etal. Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J Bone Miner Res 1993; 8: 597-605.
35. Lucas AR, Melton LJ 3rd, Crowson CS, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 1999; 74: 972-977.
36. Naessen S, Carlstrom K, Glant R, Jacobsson H, Hirschberg AL. Bone mineral density in bulimic women-influence of endocrine factors and previous anorexia. Eur J Endocrinol 2006; 155: 245-251.
37. Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T, Takano K. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J Clin Endocrinol Metab 2000; 85: 200-206.
38. Miller KK. Mechanisms by which nutritional disorders cause reduced bone mass in adults. J Womens Health (Larchmt) 2003; 12: 145-150.
39. Grinspoon SK, Baum HB, Kim V, Coggins C, Klibanski A. Decreased bone formation and increased mineral dissolution during acute fasting in young women. J Clin Endocrinol Metab 1995; 80: 3628-3633.
40. Ihle R, Loucks AB. Dose-response relationships between energy availability and bone turnover in young exercising women. J Bone Miner Res 2004; 19: 1231-1240.
41. Dominguez J, Goodman L, Sen Gupta S etal. Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. Am J Clin Nutr 2007; 86: 92-99.
42. Compston JE, McConachie C, Stott C etal. Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos Int 2006; 17: 77-84.
43. Bolton JG, Patel S, Lacey JH, White S. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 2005; 16: 1955-1962.
44. Kitchin B, Morgan SL. Not just calcium and vitamin D: other nutritional considerations in osteoporosis. Curr Rheumatol Rep 2007; 9: 85-92.
45. Abrams SA, Silber TJ, Esteban NV etal. Mineral balance and bone turnover in adolescents with anorexia nervosa. J Pediatr 1993; 123: 326-331.
46. Hadigan CM, Anderson EJ, Miller KK etal. Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord 2000; 28: 284-292.
47. Divasta AD, Feldman HA, Brown JN, Giancaterino C, Holick MF, Gordon CM. Bioavailability of vitamin D in malnourished adolescents with anorexia nervosa. J Clin Endocrinol Metab 2011; 96: 2575-2580.
48. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000; 15: 1526-1536.
49. Riggs BL. The mechanisms of estrogen regulation of bone resorption. J Clin Invest 2000; 106: 1203-1204.
50. Grinspoon S, Miller K, Coyle C etal. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999; 84: 2049-2055.
51. Miller KK, Lee EE, Lawson EA etal. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006; 91: 2931-2937.
52. Miller KK, Grinspoon S, Gleysteen S etal. Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab 2004; 89: 4434-4438.
53. Miller KK, Lawson EA, Mathur V etal. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 2007; 92: 1334-1339.
54. Gordon CM, Grace E, Emans SJ etal. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002; 87: 4935-4941.
55. Gordon CM, Goodman E, Emans SJ etal. Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatr 2002; 141: 64-70.
56. Gold PW, Gwirtsman H, Avgerinos PC etal. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med 1986; 314: 1335-1342.
57. Misra M, Miller KK, Almazan C etal. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2004; 89: 4972-4980.
58. Lo Sauro C, Ravaldi C, Cabras PL, Faravelli C, Ricca V. Stress, hypothalamic-pituitary-adrenal axis and eating disorders. Neuropsychobiology 2008; 57: 95-115.
59. Swolin-Eide D, Nilsson A, Ohlsson C. Cortisol increases growth hormone-receptor expression in human osteoblast-like cells. J Endocrinol 1998; 156: 99-105.
60. Lawson EA, Donoho D, Miller KK etal. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab 2009; 94: 4710-4716.
61. Hochberg Z, Hertz P, Colin V etal. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 1992; 41: 106-112.
62. Misra M, Miller KK, Bjornson J etal. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003; 88: 5615-5623.
63. Argente J, Caballo N, Barrios V etal. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation. J Clin Endocrinol Metab 1997; 82: 2084-2092.
64. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002; 87: 2883-2891.
65. Audi L, Vargas DM, Gussinye M, Yeste D, Marti G, Carrascosa A. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa. Pediatr Res 2002; 51: 497-504.
66. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990; 19: 35-63.
67. Bassett JH, Williams GR. Critical role of the hypothalamic-pituitary-thyroid axis in bone. Bone 2008; 43: 418-426.
68. O'Shea PJ, Bassett JH, Sriskantharajah S, Ying H, Cheng SY, Williams GR. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta. Mol Endocrinol 2005; 19: 3045-3059.
69. Wang L, Shao YY, Ballock RT. Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling. J Bone Miner Res 2007; 25: 1138-1146.
70. Moshang T Jr, Parks JS, Baker L etal. Low serum triiodothyronine in patients with anorexia nervosa. J Clin Endocrinol Metab 1975; 40: 470-473.
71. Leslie RD, Isaacs AJ, Gomez J, Raggatt PR, Bayliss R. Hypothalamo-pituitary-thyroid function in anorexia nervosa: influence of weight gain. Br Med J 1978; 2: 526-528.
72. Kvetny J. Thyroxine binding and cellular metabolism of thyroxine in mononuclear blood cells from patients with anorexia nervosa. J Endocrinol 1983; 98: 343-350.
73. Galusca B, Bossu C, Germain N etal. Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling. Osteoporos Int 2006; 17: 888-896.
74. Petersson M, Lagumdzija A, Stark A, Bucht E. Oxytocin stimulates proliferation of human osteoblast-like cells. Peptides 2002; 23: 1121-1126.
75. Breuil V, Amri EZ, Panaia-Ferrari P etal. Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition. Joint Bone Spine 2011; 78: 611-615.
76. Lawson EA, Donoho DA, Blum JI etal. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry 2011; 72: 1546-1551.
77. Misra M, Miller KK, Cord J etal. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007; 92: 2046-2052.
78. Housova J, Anderlova K, Krizova J etal. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005; 90: 1366-1370.
79. Modan-Moses D, Stein D, Pariente C etal. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 2007; 92: 1843-1847.
80. Luo XH, Guo LJ, Xie H etal. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006; 21: 1648-1656.
81. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000; 62: 413-437.
82. Misra M, Miller KK, Kuo K etal. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005; 289: E373-E381.
83. Cirmanova V, Bayer M, Starka L, Zajickova K. The effect of leptin on bone: an evolving concept of action. Physiol Res 2008; 57(Suppl. 1): S143-S151.
84. Isaia GC, D'Amelio P, Di Bella S, Tamone C. Is leptin the link between fat and bone mass? J Endocrinol Invest 2005; 28: 61-65.
85. Cohen MM Jr. Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling. Am J Med Genet A 2006; 140: 515-524.
86. Batterham RL, Cohen MA, Ellis SM etal. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349: 941-948.
87. Baldock PA, Sainsbury A, Couzens M etal. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002; 109: 915-921.
88. Misra M, Miller KK, Tsai P etal. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006; 91: 1027-1033.
89. Utz AL, Lawson EA, Misra M etal. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008; 43: 135-139.
90. Misra M, Miller KK, Kuo K etal. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005; 289: E347-E356.
91. Fukushima N, Hanada R, Teranishi H etal. Ghrelin directly regulates bone formation. J Bone Miner Res 2005; 20: 790-798.
92. Nass R, Pezzoli SS, Oliveri MC etal. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med 2008; 149: 601-611.
93. Wojcik MH, Meenaghan E, Lawson EA, Misra M, Klibanski A, Miller KK. Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone 2010; 46: 796-800.
94. Ecklund K, Vajapeyam S, Feldman HA etal. Bone marrow changes in adolescent girls with anorexia nervosa. J Bone Miner Res 2010; 25: 298-304.
95. Bredella MA, Fazeli PK, Miller KK etal. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 2009; 94: 2129-2136.
96. Fazeli PK, Bredella MA, Misra M etal. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab 2010; 95: 407-413.
97. Zaidi M, Buettner C, Sun L, Iqbal J. Minireview: the link between fat and bone: does mass beget mass? Endocrinology 2012; 153: 2070-2075.
98. Howgate DJ, Graham SM, Leonidou A, Korres N, Tsiridis E, Tsapakis E. Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities. Osteoporos Int 2013; 24: 407-421.
99. Bruni V, Filicetti MF, Pontello V. Open issues in anorexia nervosa: prevention and therapy of bone loss. Ann N Y Acad Sci 2006; 1092: 91-102.
100. Bachrach LK, Katzman DK, Litt IF, Guido D, Marcus R. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 1991; 72: 602-606.
101. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995; 80: 898-904.
102. Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker IR. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 2002; 15: 135-143.
103. Legroux-Gerot I, Vignau J, Collier F, Cortet B. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy. Calcif Tissue Int 2008; 83: 315-323.
104. Golden NH. Eating disorders in adolescence: what is the role of hormone replacement therapy? Curr Opin Obstet Gynecol 2007; 19: 434-439.
105. Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 1991; 72: 374-381.
106. Misra M, Katzman D, Miller KK etal. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011; 26: 2430-2438.
107. Faje AT, Fazeli PK, Katzman D etal. Inhibition of Pref-1 (preadipocyte factor 1) by estradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density. Clin Endocrinol (Oxf) 2013; 79: 326-332.
108. Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 2005; 90: 1428-1433.
109. Miller KK, Meenaghan E, Lawson EA etal. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2011; 96: 2081-2088.
110. Fazeli PK, Lawson EA, Prabhakaran R etal. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2010; 95: 4889-4897.
111. Lloyd T, Chinchilli VM, Johnson-Rollings N, Kieselhorst K, Eggli DF, Marcus R. Adult female hip bone density reflects teenage sports-exercise patterns but not teenage calcium intake. Pediatrics 2000; 106: 40-44.
112. Putukian M. The female athlete triad. Clin Sports Med 1998; 17: 675-696, v.
113. Waugh EJ, Woodside DB, Beaton DE, Cote P, Hawker GA. Effects of exercise on bone mass in young women with anorexia nervosa. Med Sci Sports Exerc 2011; 43: 755-763.
114. Miller KK, Grieco KA, Mulder J etal. Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 2004; 89: 3903-3906.
115. Golden NH, Iglesias EA, Jacobson MS etal. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005; 90: 3179-3185.
116. Gerard N, Pieters G, Goffin K, Bormans G, Van Laere K. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa. Biol Psychiatry 2011; 70: 777-784.
117. Stoving RK, Andries A, Brixen K, Flyvbjerg A, Horder K, Frystyk J. Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa. J Psychiatr Res 2009; 43: 671-679.
118. Gaetani S, Kaye WH, Cuomo V, Piomelli D. Role of endocannabinoids and their analogues in obesity and eating disorders. Eat Weight Disord 2008; 13: e42-e48.
119. Verty AN, Evetts MJ, Crouch GJ, McGregor IS, Stefanidis A, Oldfield BJ. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology 2011; 36: 1349-1358.
120. Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984; 311: 1601-1606.
121. Halvorsen I, Platou D, Hoiseth A. Bone mass eight years after treatment for adolescent-onset anorexia nervosa. Eur Eat Disord Rev 2012; 20: 386-392.